In a filing, Elanco Animal Health Inc revealed its Director HOOVER R DAVID acquired Company’s shares for reported $0.27 million on Mar 05 ’25. In the deal valued at $10.90 per share,25,000 shares were bought. As a result of this transaction, HOOVER R DAVID now holds 210,000 shares worth roughly $2.34 million.
Then, Harrington Michael J bought 3,500 shares, generating $51,974 in total proceeds. Upon buying the shares at $14.85, the Director now owns 81,094 shares.
Before that, Simmons Jeffrey N bought 100,000 shares. Elanco Animal Health Inc shares valued at $1,300,610 were divested by the PRESIDENT, CEO AND DIRECTOR at a price of $13.01 per share. As a result of the transaction, Simmons Jeffrey N now holds 145,000 shares, worth roughly $1.62 million.
UBS initiated its Elanco Animal Health Inc [ELAN] rating to a Buy in a research note published on December 09, 2024; the price target was $18. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in early December with a ‘”a Market perform”‘ rating. Morgan Stanley also remained covering ELAN and has decreased its forecast on September 19, 2024 with a “an Equal-weight” recommendation from previously “an Overweight” rating. Stifel revised its rating on January 05, 2024. It rated ELAN as “a Buy” which previously was an “a Hold”.
Price Performance Review of ELAN
On Friday, Elanco Animal Health Inc [NYSE:ELAN] saw its stock jump 2.86% to $11.14. Over the last five days, the stock has lost -0.27%. Elanco Animal Health Inc shares have fallen nearly -8.01% since the year began. Nevertheless, the stocks have fallen -30.33% over the past one year. While a 52-week high of $18.80 was reached on 01/30/25, a 52-week low of $10.20 was recorded on 02/25/25. SMA at 50 days reached $11.63, while 200 days put it at $13.65.
Levels Of Support And Resistance For ELAN Stock
The 24-hour chart illustrates a support level at 10.87, which if violated will result in even more drops to 10.60. On the upside, there is a resistance level at 11.28. A further resistance level may holdings at 11.41. The Relative Strength Index (RSI) on the 14-day chart is 46.77, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.11, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 27.41%. Stochastics %K at 51.37% indicates the stock is a holding.
The most recent change occurred on December 19, 2023 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $17 price target.
